NCT06885229

Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations

Reuseable Face Masks to Reduce Risk of Viral Respiratory Infections and Exacerbations in Adults With Asthma: a Randomised Controlled Trial

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Queen Mary University of London · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Accepted

Summary

REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to adults with asthma and other members of their household reduces risk of RT-PCR confirmed viral respiratory infections and asthma exacerbations.

Conditions

• Acute Respiratory Infection
• Asthma Exacerbations

Interventions

Type	Name	Description
DEVICE	FloMask - reuseable face mask	Reuseable, elastomeric face mask with replaceable filters

Timeline

• Start date: 2025-03-27
• Primary completion: 2025-04-01
• Completion: 2025-04-01
• First posted: 2025-03-20
• Last updated: 2025-05-20

Locations

1 site across 1 country: United Kingdom